Pathogenesis and prevention of cholera

Lack of Fc Gamma Receptor IIIA Promotes Rather than Suppresses Humoral and Cellular Immune Responses after Mucosal or Parenteral Immunization with Antigen and Adjuvants.

Scandinavian journal of immunology·2017

Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.

Vaccine·2013

Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.

Vaccine·2013

Anti-bacterial and anti-toxic immunity induced by a killed whole-cell-cholera toxin B subunit cholera vaccine is essential for protection against lethal bacterial infection in mouse pulmonary cholera model.

Mucosal immunology·2012

Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues.

Current topics in microbiology and immunology·2010

Topical immunization strategies.

Mucosal immunology·2010

Annual disease burden due to human papillomavirus 16 and 18 infections in Finland.

Scandinavian journal of infectious diseases. Supplementum·2009

Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.

Scandinavian journal of infectious diseases. Supplementum·2009

Brief summary of the legal proceeding.

Scandinavian journal of infectious diseases. Supplementum·2004

Genotypic resistance tests for the management of postexposure prophylaxis.

Scandinavian journal of infectious diseases. Supplementum·2004

Genotypic resistance tests for the management of the patient failing highly active antiretroviral therapy: the resistance pattern in different biological compartments.

Scandinavian journal of infectious diseases. Supplementum·2004

Genotypic resistance tests for the management of the HIV-infected pregnant patient in Africa.

Scandinavian journal of infectious diseases. Supplementum·2004

Knowledge and Awareness of HPV, the HPV Vaccine, and Cervical Cancer Among Women From a Brazilian Community: A Community-Based Cross-Sectional Study.

Health science reports·2026

Improving fidelity of implementation of self-administered pulse oximetry and remote patient monitoring in Honduras during the COVID-19 pandemic.

Frontiers in medicine·2026

Preventive Measures and Crowd Management Strategies to Mitigate the Risk of Stampedes in Public Gatherings: A Systematic Review.

Public health reviews·2026

From awareness to action: a comparative study of family medical history and preventive health behaviors in Saudi Arabia and Syria.

Frontiers in public health·2026

Individual-level HPV vaccination verification in Botswana: lessons learned from implementation of the HOPE II trial.

Frontiers in public health·2026

Follow-Up and Outcomes After Thermal Ablation Treatment Among HIV-Infected Women From Resource-Limited Countries With Positive HPV-Based Screening: Results of the AIMA-CC Cohort (ANRS 12375).

International journal of cancer·2026

Related Experiment Videos

Pathogenesis and prevention of cholera

Related Concept Videos

Lack of Fc Gamma Receptor IIIA Promotes Rather than Suppresses Humoral and Cellular Immune Responses after Mucosal or Parenteral Immunization with Antigen and Adjuvants.

Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.

Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.

Anti-bacterial and anti-toxic immunity induced by a killed whole-cell-cholera toxin B subunit cholera vaccine is essential for protection against lethal bacterial infection in mouse pulmonary cholera model.

Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues.

Topical immunization strategies.

Annual disease burden due to human papillomavirus 16 and 18 infections in Finland.

Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.

Brief summary of the legal proceeding.

Genotypic resistance tests for the management of postexposure prophylaxis.

Genotypic resistance tests for the management of the patient failing highly active antiretroviral therapy: the resistance pattern in different biological compartments.

Genotypic resistance tests for the management of the HIV-infected pregnant patient in Africa.

Knowledge and Awareness of HPV, the HPV Vaccine, and Cervical Cancer Among Women From a Brazilian Community: A Community-Based Cross-Sectional Study.

Improving fidelity of implementation of self-administered pulse oximetry and remote patient monitoring in Honduras during the COVID-19 pandemic.

Preventive Measures and Crowd Management Strategies to Mitigate the Risk of Stampedes in Public Gatherings: A Systematic Review.

From awareness to action: a comparative study of family medical history and preventive health behaviors in Saudi Arabia and Syria.

Individual-level HPV vaccination verification in Botswana: lessons learned from implementation of the HOPE II trial.

Follow-Up and Outcomes After Thermal Ablation Treatment Among HIV-Infected Women From Resource-Limited Countries With Positive HPV-Based Screening: Results of the AIMA-CC Cohort (ANRS 12375).

Related Experiment Videos

Pathogenesis and prevention of cholera

Related Concept Videos

Related Articles